Skip to main content

New Executive Officers of the Children’s Tumor Foundation Board of Directors

By November 17, 2016February 28th, 2024Press Release

The Children’s Tumor Foundation is pleased to announce newly elected executive officers of the Board of Directors. These exemplary individuals will help guide the Foundation toward our goals for 2017 and beyond.
Richard Horvitz will serve as the new Chair of the Board of Directors. Mr. Horvitz is currently the Chairman of Moreland Management Company, a closely-held private family investment office based in Ohio. He has been involved with the Foundation since 1996, and previously served as Chair from 2002-2006.


Tracy Galloway will fulfill the role of Vice Chair. Mrs. Galloway has been a member of the Board since 2011. She is an avid supporter of the Synodos model, and has specifically backed the Synodos for NF2 initiative since its inception in 2014.


Gabriel Groisman will serve as the new Secretary of the Board. Mr. Groisman is a Shareholder at the Miami-based law firm, Coffey Burlington, P.L., where he specializes in trademark law and complex commercial litigation. He became a member of the Board in June 2016.

Randall Stanicky will continue his role as Treasurer for a second term. Mr. Stanicky currently serves as Managing Director of Global Equity Research at RBC Capital Markets, focusing on the specialty pharmaceuticals sector. He has served on the Board since 2015, and brings both his financial background and knowledge of the healthcare sector to the Foundation.

To read the complete biographies of the Board’s officers as well as all the members of the Foundation’s Board of Directors, click here.